Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.

Late last week in Morbidity and Mortality Weekly Report, authors from the Centers for Disease Control and Prevention (CDC) ...

A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against ... Orders have also been placed for shots made by French company Valneva and Johnson & Johnson subsidiary ...

The price of bitcoin fell below $90,000 and other cryptocurrencies saw large drops Tuesday morning, erasing some of the gains ...

The use of lab-made parts of the virus for a vaccine is a well-established ... On 20 December 2021, the EU authorised the first protein-based vaccine (produced by Novavax) for use in the EU, following ...

Kennedy has been a vocal skeptic of vaccines and repeatedly made false claims that they cause ... fourth-quarter results Tuesday. Shares of Novavax and BioNTech, two more vaccine companies ...

A protein-based booster vaccine made by Novavax, which works differently to the Pfizer and Moderna jabs, is also available. Moderna is hoping to launch a combined flu and Covid vaccine in 2025 or ...

Kennedy made the pledges to Senator ... along with U.S. shares of its COVID-19 vaccine partner, BioNTech, which was down 3%. Moderna was down 5.1% and Novavax down around 1%.